84 related articles for article (PubMed ID: 17130548)
1. New members of the interleukin-12 family of cytokines: IL-23 and IL-27 modulate autoimmune diabetes.
Mensah-Brown EP; Shahin A; Al-Shamsi M; Lukic ML
Ann N Y Acad Sci; 2006 Oct; 1079():157-60. PubMed ID: 17130548
[TBL] [Abstract][Full Text] [Related]
2. IL-23 leads to diabetes induction after subdiabetogenic treatment with multiple low doses of streptozotocin.
Mensah-Brown EP; Shahin A; Al-Shamisi M; Wei X; Lukic ML
Eur J Immunol; 2006 Jan; 36(1):216-23. PubMed ID: 16358360
[TBL] [Abstract][Full Text] [Related]
3. Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin.
Herold KC; Vezys V; Sun Q; Viktora D; Seung E; Reiner S; Brown DR
J Immunol; 1996 May; 156(9):3521-7. PubMed ID: 8617981
[TBL] [Abstract][Full Text] [Related]
4. Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: Fc construct.
Nicoletti F; Di Marco R; Papaccio G; Conget I; Gomis R; Bernardini R; Sims JE; Shoenfeld Y; Bendtzen K
Eur J Immunol; 2003 Aug; 33(8):2278-86. PubMed ID: 12884303
[TBL] [Abstract][Full Text] [Related]
5. Young NOD mice show increased diabetes sensitivity to low doses of streptozotocin.
Reddy S; Chang M; Robinson E
Ann N Y Acad Sci; 2006 Oct; 1079():109-13. PubMed ID: 17130539
[TBL] [Abstract][Full Text] [Related]
6. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
7. Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice.
Amirshahrokhi K; Dehpour AR; Hadjati J; Sotoudeh M; Ghazi-Khansari M
Toxicol Appl Pharmacol; 2008 Oct; 232(1):119-24. PubMed ID: 18671992
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 promotes hyperglycemia and insulitis in mice normally resistant to streptozotocin-induced diabetes.
Zunino SJ; Simons LF; Sambrook JF; Gething MJ
Am J Pathol; 1994 Sep; 145(3):661-70. PubMed ID: 8080048
[TBL] [Abstract][Full Text] [Related]
9. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection.
Callewaert HI; Gysemans CA; Ladrière L; D'Hertog W; Hagenbrock J; Overbergh L; Eizirik DL; Mathieu C
Diabetes; 2007 Aug; 56(8):2169-73. PubMed ID: 17473223
[TBL] [Abstract][Full Text] [Related]
10. Immune regulation at the interface during early steps of murine implantation: involvement of two new cytokines of the IL-12 family (IL-23 and IL-27) and of TWEAK.
Mas AE; Petitbarat M; Dubanchet S; Fay S; Ledée N; Chaouat G
Am J Reprod Immunol; 2008 Apr; 59(4):323-38. PubMed ID: 18336386
[TBL] [Abstract][Full Text] [Related]
11. Elevation of tumor necrosis factor-alpha, interleukin-1beta and interleukin-6 levels in aortic intima of Chinese Guizhou minipigs with streptozotocin-induced diabetes.
Lu L; Zhang Q; Pu LJ; Xu XW; Zhang RY; Zhang JS; Hu J; Yang ZK; Lü AK; Ding FH; Shen J; Chen QJ; Lou S; Fang DH; Shen WF
Chin Med J (Engl); 2007 Mar; 120(6):479-84. PubMed ID: 17439741
[TBL] [Abstract][Full Text] [Related]
12. c-Jun amino terminal kinase 1 deficient mice are protected from streptozotocin-induced islet injury.
Fukuda K; Tesch GH; Nikolic-Paterson DJ
Biochem Biophys Res Commun; 2008 Feb; 366(3):710-6. PubMed ID: 18082135
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin deficiency impacts the pancreatic TH1/TH2 cytokine profile following multiple low dose streptozotocin-induced diabetes.
Arafat HA; Lada E; Katakam AK; Amin N
Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):555-62. PubMed ID: 17177137
[TBL] [Abstract][Full Text] [Related]
14. The radical scavenger edaravone counteracts diabetes in multiple low-dose streptozotocin-treated mice.
Fukudome D; Matsuda M; Kawasaki T; Ago Y; Matsuda T
Eur J Pharmacol; 2008 Mar; 583(1):164-9. PubMed ID: 18291360
[TBL] [Abstract][Full Text] [Related]
15. NO-mediated cytotoxicity contributes to multiple low-dose streptozotocin-induced diabetes but not to NOD diabetes.
Yasuda H; Jin Z; Nakayama M; Yamada K; Kishi M; Okumachi Y; Arai T; Moriyama H; Yokono K; Nagata M
Diabetes Res Clin Pract; 2009 Feb; 83(2):200-7. PubMed ID: 19117633
[TBL] [Abstract][Full Text] [Related]
16. Targeted disruption of the galectin-3 gene results in decreased susceptibility to multiple low dose streptozotocin-induced diabetes in mice.
Mensah-Brown EP; Al Rabesi Z; Shahin A; Al Shamsi M; Arsenijevic N; Hsu DK; Liu FT; Lukic ML
Clin Immunol; 2009 Jan; 130(1):83-8. PubMed ID: 18845486
[TBL] [Abstract][Full Text] [Related]
17. Newly weaned nonobese diabetic mice show heightened early diabetes sensitivity to multiple low doses of streptozotocin than nondiabetes-prone CD-1 mice: initial beta-cell damage a key trigger for type 1 diabetes?
Reddy S; Elliott RB; Chang M; Hsu T; Rodrigues JA; Qiao L; Robinson E
Pancreas; 2008 Jul; 37(1):e8-e19. PubMed ID: 18580436
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus.
Stosic-Grujicic S; Stojanovic I; Maksimovic-Ivanic D; Momcilovic M; Popadic D; Harhaji L; Miljkovic D; Metz C; Mangano K; Papaccio G; Al-Abed Y; Nicoletti F
J Cell Physiol; 2008 Jun; 215(3):665-75. PubMed ID: 18064633
[TBL] [Abstract][Full Text] [Related]
19. Effect of cyclosporin A on low-dose streptozotocin diabetes in mice.
Kolb H; Oschilewski M; Schwab E; Oschilewski U; Kiesel U
Diabetes Res; 1985 Jul; 2(4):191-3. PubMed ID: 3910327
[TBL] [Abstract][Full Text] [Related]
20. Insights into modeling streptozotocin-induced diabetes in ICR mice.
Dekel Y; Glucksam Y; Elron-Gross I; Margalit R
Lab Anim (NY); 2009 Feb; 38(2):55-60. PubMed ID: 19165193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
